1-13 of 13
Francoise Kraeber-Bodere
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Primary Mediastinal B-Cell Lymphoma Patients Treated with a PET-Guided Strategy in the Randomized Phase 3 Gained Study Conducted By Lysa

Vincent Camus, Thierry Jo Molina, Fabienne Desmots-Loyer, Amine Moslemi, Philippe Ruminy, Steven Le Gouill, Herve Ghesquieres, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Vincent Ribrag, Roch Houot, Catherine Thieblemont, Herve Maisonneuve, Fabien Claves, Krimo Bouabdallah, Corinne Haioun, Gandhi Damaj, Luc-Matthieu Fornecker, Robin Noel, Pierre Feugier, David Sibon, Guillaume Cartron, Christophe Bonnet, Marc André, Françoise Kraeber-Bodéré, Caroline Milin, Jean-Philippe Jais, Josette Briere, Olivier Casasnovas, Salim Kanoun, Emmanuel Itti, Paul Blanc-Durand, Mad-Hélénie Elsensohn, Loic Chartier, Fabrice Jardin, Thierry Fest
Journal: Blood
Blood (2024) 144 (Supplement 1): 575.
https://doi.org/10.1182/blood-2024-202446
Published: 2024
Journal Articles

Prognostic Value of Positron Emission Tomography/Computed Tomography in Multiple Myeloma Patients Treated with Ide-Cel CAR-T Cell Therapy: Preliminary Results of a Real-World IFM Study from the Descar-T Registry (CAR MY PET)

Bertrand Arnulf, Laetitia Vercellino, Denis Caillot, Jérôme Lambert, Bastien Jamet, Aurore Perrot, Pierre Bories, Olivier Decaux, Lionel Karlin, Anne Lazareth, Laure Vincent, Christine Latry Kuhn, Cyrille Touzeau, Harel Stephanie, Mohamad Mohty, Florent Malard, Salomon Manier, Ibrahim Yakoub-Agha, Alexis Talbot, Niels Moya, Arthur Bobin, Marie-Odile Petillon, Noemie Bigot, Thierry Facon, Jill Corre, Herve Avet-Loiseau, Philippe Moreau, Françoise Kraeber-Bodéré
Journal: Blood
Blood (2024) 144 (Supplement 1): 4765.
https://doi.org/10.1182/blood-2024-206867
Published: 2024
Journal Articles

Early Metabolic Response and Tmtv Are Key Predictors of Control of Relapse/Refractory Follicular Lymphoma Treated with CAR-T Cells : Preliminary Results from the French Descar-T Registry

Yassine Al Tabaa, Xavier Pallard, Loic Ysebaert, Emmanuel Bachy, Franck Morschhauser, Roch Houot, Guillaume Cartron, Catherine Thieblemont, Didier Blaise, Cedric Rossi, Francoise Kraeber-Bodere, Benoit Tessoulin, Fabien Le Bras, Olivier Hermine, Emelie Van Zele, Vivien Dupont, Romain Ricci
Journal: Blood
Blood (2024) 144 (Supplement 1): 7131.
https://doi.org/10.1182/blood-2024-200968
Published: 2024
Journal Articles

Low Tmtv Influences Response and Outcomes in R/R DLBCL 3L+ Patients Treated with CAR-T Cells : First Results of FDG-PET/CT Analysis in the French Descar-T Registry

Yassine Al Tabaa, Clément Bailly, Xavier Pallard, Anne Ségolène Cottereau, Jérémie Tordo, Pierre Sesques, Guillaume Cartron, Roch Houot, Roberta Di Blasi, Salim Kanoun, Caroline Milin, Françoise Kraeber-Bodéré, Laetitia Vercellino
Journal: Blood
Blood (2023) 142 (Supplement 1): 3019.
https://doi.org/10.1182/blood-2023-185794
Published: 2023
Journal Articles

Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA

Clinical Trials & Observations
Steven Le Gouill, Hervé Ghesquières, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Vincent Ribrag, Thierry Lamy, Catherine Thieblemont, Hervé Maisonneuve, Rémy Gressin, Krimo Bouhabdallah, Corinne Haioun, Gandhi Damaj, Luc Fornecker, Réda Bouhabdallah, Pierre Feugier, David Sibon, Guillaume Cartron, Christophe Bonnet, Marc André, Loic Chartier, Philippe Ruminy, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Alina Berriolo-Riedinger, Josette Brière, Jean-Philippe Jais, Thierry Jo Molina, Emmanuel Itti, René-Olivier Casasnovas
Journal: Blood
Blood (2021) 137 (17): 2307–2320.
https://doi.org/10.1182/blood.2020008750
Published: 2021
Includes: Supplemental data
Journal Articles

Genome-Wide Transcriptome Analysis Identifies Molecular Patterns of FDG-PET/CT Biomarkers in MM Patients from the Cassiopet Study

Jean-Baptiste Alberge, Bastien Jamet, Clement Bailly, Cyrille Touzeau, Jonathan Cruard, Thomas Carlier, Caroline Bodet-Milin, Michel Cherel, Philippe Moreau, MD, Stephane Minvielle, Francoise Kraeber-Bodere
Journal: Blood
Blood (2020) 136 (Supplement 1): 26.
https://doi.org/10.1182/blood-2020-140235
Published: 2020
Journal Articles

Evaluation of the Prognostic Value of Positron Emission Tomography-Computed Tomography (PET-CT) at Diagnosis and Follow-up in Transplant-Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients Treated in the Phase 3 Cassiopeia Study: Results of the Cassiopet Companion Study

Philippe Moreau, MD, Sonja Zweegman, Aurore Perrot, MD PhD, Cyrille Hulin, MD, Denis Caillot, MD, Thierry Facon, MD, Xavier Leleu, MD PhD, Karim Belhadj, Lionel Karlin, MD, Lotfi Benboubker, MD, Mark-David Levin, MD PhD, Monique C. Minnema, MD PhD, Bastien Jamet, Caroline Bodet-Milin, Pieter Sonneveld, Jérôme Lambert, Lixia Pei, Carla de Boer, Jessica Vermeulen, MD PhD, Tobias Kampfenkel, MD, Francoise Kraeber-Bodere
Journal: Blood
Blood (2019) 134 (Supplement_1): 692.
https://doi.org/10.1182/blood-2019-123143
Published: 2019
Journal Articles

Standardization of 18F-FDG PET/CT According to Deauville Criteria for MRD Evaluation in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Joined Analysis of Two Prospective Randomized Phase III Trials

Elena Zamagni, MD, Cristina Nanni, Luca Dozza, MSc, Thomas Carlier, Paola Tacchetti, MD PhD, Annibale Versari, Stephane Chauvie, Andrea Gallamini, MD, Michel Attal, Barbara Gamberi, MD, Denis Caillot, Francesca Patriarca, MD, Margaret Macro, Mario Boccadoro, MD, Laurent Garderet, Stefano Fanti, Aurore Perrot, Francesca Gay, MD, Pieter Sonneveld, MDPhD, Lionel Karlin, MD, Michele Cavo, MD, Caroline Bodet-Milin, Philippe Moreau, Francoise Kraeber-Bodere
Journal: Blood
Blood (2018) 132 (Supplement 1): 257.
https://doi.org/10.1182/blood-2018-99-111321
Published: 2018
Journal Articles

Impact of Early Post-Transplant 5-Point Deauville Scale (18)F-FDG-PET Status on Survival Outcomes after Allogeneic Transplantation for Lymphoma

Louise Bouard, Caroline Bodet-Milin, Thierry Guillaume, MD PhD, Pierre Peterlin, MD, Clement Bailly, Alice Garnier, MD, Amandine Le Bourgeois, PhD, Beatrice Mahe, MD, Viviane Dubruille, MD, Nicolas Blin, Pierre Gallas, MD, Cyrille Touzeau, MD PhD, Thomas Gastinne, MD, Anne Lok, MD, Lucie Planche, Steven Le Gouill, MDPhD, Philippe Moreau, MDPhD, Francoise Kraeber-Bodere, Patrice Chevallier, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3266.
https://doi.org/10.1182/blood.V130.Suppl_1.3266.3266
Published: 2017
Journal Articles

Predictive Power of FDG-PET Parameters at Diagnosis and after Induction in Patients with Mantle Cell Lymphoma, Interim Results from the LyMa-PET Project, Conducted on Behalf of the Lysa Group

Caroline Bodet-Milin, Clement Bailly, Michel Meignan, Alina Beriollo-Riedinger, Rene-Olivier Casasnovas, MD, Anne Devillers, Thierry Lamy, PhD MD, Maria Santiago-Ribeiro, Emmanuel Gyan, MD PhD, Céline Gallazzini-Crépin, Remy Gressin, MD, Thomas Carlier, Francoise Kraeber-Bodéré, Olivier Hermine, Steven Le Gouill, MD PhD
Journal: Blood
Blood (2015) 126 (23): 335.
https://doi.org/10.1182/blood.V126.23.335.335
Published: 2015
Journal Articles

Cell-of-Origin (COO) Classification, BCL2 and MYC Expression Associated-Outcome in Younger Patients Treated By RCHOP Front-Line Therapy Versus Intensive Regimen Followed By Autologous Transplant for De Novo Advanced Diffuse Large B Cell Lymphoma (DLBCL) : Results of the French Prospective Multicenter Randomized Trial Goelams -075

Gaëlle Labouré, Marie-Cécile Parrens, MD, Anjarasoa Tsaranazy, Magali Bordier, Steven Le Gouill, MD PhD, Vincent Delwail, MD, Remy Gressin, MD, Jérôme Cornillon, MD, Gandhi Damaj, MD PhD, Charles Yves Foussard, MD, Herve Maisonneuve, MD, Eric Deconinck, MD PhD, Guillaume Cartron, MD PhD, Francois Dreyfus, MD, Emmanuel Gyan, MD PhD, Laurent Sutton, MD, Nadine Morineau, MD, Magda Alexis, Anne Banos, MD, Diane Damotte, MD PhD, Anne Moreau, MD, Françoise Kraeber-Bodéré, MD PhD, Delphine Rossille, PhD, Thierry Fest, MD PhD, Thierry Lamy, MD PhD, Noel Milpied, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3920.
https://doi.org/10.1182/blood.V126.23.3920.3920
Published: 2015
Journal Articles

Phase 1 Dose-Escalation Study of 90 yttrium-Labeled Anti-CD22 Epratuzumab Tetraxetan in Adults with Refractory/Relapsed CD22 + B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Patrice Chevallier, MD PhD, Thomas Eugene, MD, Nelly Robillard, Françoise Isnard, MD, Franck E Nicolini, MD PhD, Martine Escoffre-Barbe, MD, Françoise Huguet, Mathilde Hunault, Antoine Marcais, MD, Thierry Guillaume, Jacques Delaunay, MD, Pierre Peterlin, MD, Xavier Thomas, MD PhD, Norbert Ifrah, Simona Lapusan, Caroline bodet-Milin, MD, Alain faivre Chauvet, Claire Le Houerou, David M Goldenberg, ScD, MD, William A Wegener, MD PhD, Françoise Kraeber-Bodere, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3708.
https://doi.org/10.1182/blood.V124.21.3708.3708
Published: 2014
Journal Articles

BCR-ABL1 Molecular Remission After 90 y-Epratuzumab Tetraxetan Radioimmunotherapy In CD22 + Ph + B-ALL: A Potential New Treatment Paradigm

Patrice Chevallier, MD, PhD, Caroline bodet-Milin, MD, Nelly Robillard, Thomas Eugene, MD, Audrey Ménard, Claire Le Houerou, Thierry Guillaume, MD, Jacques Delaunay, MD, Martine Escoffre-Barbe, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD, Françoise kraeber-Bodere, MD
Journal: Blood
Blood (2013) 122 (21): 3910.
https://doi.org/10.1182/blood.V122.21.3910.3910
Published: 2013